Neurodegenerative diseases, art and creativity: therapeutic implications

References

• 1. Dugger BN, Dickson DW. Pathology of neurodegenerative diseases. Cold Spring Harb. Perspect. Biol. 9(7), 1–22 (2017).
  Google Scholar
• 2. Gretton C, Ffytche DH. Art and the brain: a view from dementia. Int. J. Geriatr. Psychiatry 29(2), 111–126 (2014).
  MedlineGoogle Scholar
• 3. Braak H, Del Tredici K, Rüb U, De Vos RAI, Jansen Steur ENH, Braak E. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol. Aging 24(2), 197–211 (2003).
  MedlineGoogle Scholar
• 4. Cucca A, Di Rocco A, Acosta I et al. Art therapy for Parkinson’s disease. Park. Relat. Disord. 84, 148–154 (2021).
  MedlineGoogle Scholar
• 5. Yu J, Rawtaer I, Goh LG et al. The art of remediating age-related cognitive decline: art therapy enhances cognition and increases cortical thickness in mild cognitive impairment. J. Int. Neuropsychol. Soc. 27(1), 79–88 (2021).
  MedlineGoogle Scholar
• 6. Pelowski M, Markey PS, Forster M, Gerger G, Leder H. Move me, astonish me… delight my eyes and brain: the Vienna Integrated Model of top-down and bottom-up processes in Art Perception (VIMAP) and corresponding affective, evaluative, and neurophysiological correlates. Phys. Life Rev. 21, 80–125 (2017).
  MedlineGoogle Scholar
• 7. Spee B, Ishizu T, Leder H, Mikuni J, Kawabata H, Pelowski M. Neuropsychopharmacological aesthetics: a theoretical consideration of pharmacological approaches to causative brain study in aesthetics and art. Prog. Brain Res. 237, 343–372 (2018).
  MedlineGoogle Scholar
• 8. Lauring JO, Ishizu T, Kutlikova HH et al. Why would Parkinson's disease lead to sudden changes in creativity, motivation, or style with visual art?: a review of case evidence and new neurobiological, contextual, and genetic hypotheses. Neurosci. Biobehav. Rev. 100(February), 129–165 (2019).
  MedlineGoogle Scholar
• 9. Haaxma CA, Borm GF, van der Linden D, Kappelle AC, Bloem BR. Artistic occupations are associated with a reduced risk of Parkinson's disease. J. Neurol. 262(9), 2171–2176 (2015).
  MedlineGoogle Scholar
• 10. Pelowski M, Spee B, Richard A, Krack P, Bloem B. What Parkinson’s reveals about the artistic spark. Am. Sci. 108(4), 240 (2020).
  Google Scholar
• 11. Lhommée E, Batir A, Quesada J-L et al. Dopamine and the biology of creativity: lessons from Parkinson’s disease. Front. Neurol. 5(April), 55 (2014).
  MedlineGoogle Scholar
• 12. Inzelberg R. The awakening of artistic creativity and Parkinson’s disease. Behav. Neurosci. 127(2), 256–261 (2013).
  MedlineGoogle Scholar
• 13. Kulisevsky J, Pagonabarraga J, Martinez-Corral M. Changes in artistic style and behaviour in Parkinson’s disease: dopamine and creativity. J. Neurol. 256(5), 816–819 (2009).
  MedlineGoogle Scholar
• 14. Garcia-Ruiz PJ. Impulse control disorders and dopamine-related creativity: pathogenesis and mechanism, short review, and hypothesis. Front. Neurol. 9(December), 1–6 (2018).
  MedlineGoogle Scholar
• 15. Boot N, Baas M, van Gaal S, Cools R, De Dreu CKW. Creative cognition and dopaminergic modulation of fronto-striatal networks: integrative review and research agenda. Neurosci. Biobehav. Rev. 78, 13–23 (2017).
  Medline CASGoogle Scholar
• 16. Seeman P. Parkinson’s disease treatment may cause impulse-control disorder via dopamine D3 receptors. Synapse 69(4), 183–189 (2015).
  Medline CASGoogle Scholar
• 17. Canesi M, Rusconi ML, Isaias IU, Pezzoli G. Artistic productivity and creative thinking in Parkinson’s disease. Eur. J. Neurol. 19(3), 468–472 (2012).
  Medline CASGoogle Scholar
• 18. Garcia-Ruiz PJ, Martinez Castrillo JC, Desojo LV. Creativity related to dopaminergic treatment: a multicenter study. Park. Relat. Disord. 63(January), 169–173 (2019).
  MedlineGoogle Scholar
• 19. Ringman JM. The Huntington disease of Woody Guthrie: another man done gone. Cogn. Behav. Neurol. 20(4), 238–243 (2007).
  MedlineGoogle Scholar
• 20. Herholz SC, Herholz RS, Herholz K. Non-pharmacological interventions and neuroplasticity in early stage Alzheimer’s disease. Expert Rev. Neurother. 13(11), 1235–1245 (2013).
  Medline CASGoogle Scholar